BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 31707836)

  • 21. Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant.
    Rhee JW; Pillai R; He T; Bosworth A; Chen S; Atencio L; Oganesyan A; Peng K; Guzman T; Lukas K; Sigala B; Iukuridze A; Lindenfeld L; Jamal F; Natarajan P; Goldsmith S; Krishnan A; Rosenzweig M; Wong FL; Forman SJ; Armenian S
    JAMA Cardiol; 2024 Jan; 9(1):16-24. PubMed ID: 37938837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort.
    Khandaker GM; Zammit S; Burgess S; Lewis G; Jones PB
    Brain Behav Immun; 2018 Mar; 69():264-272. PubMed ID: 29197507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
    Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
    Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Disease, Aging, and Clonal Hematopoiesis.
    Evans MA; Sano S; Walsh K
    Annu Rev Pathol; 2020 Jan; 15():419-438. PubMed ID: 31689371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups.
    Georgakis MK; Malik R; Richardson TG; Howson JMM; Anderson CD; Burgess S; Hovingh GK; Dichgans M; Gill D
    BMC Med; 2022 Aug; 20(1):245. PubMed ID: 35948913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review.
    Senguttuvan NB; Subramanian V; Venkatesan V; Muralidharan TR; Sankaranarayanan K
    J Genet Eng Biotechnol; 2021 Jul; 19(1):105. PubMed ID: 34279740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions.
    Mehta A; Mahtta D; Gulati M; Sperling LS; Blumenthal RS; Virani SS
    Curr Atheroscler Rep; 2020 Jan; 22(1):3. PubMed ID: 31927694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.
    Calvillo-Argüelles O; Jaiswal S; Shlush LI; Moslehi JJ; Schimmer A; Barac A; Thavendiranathan P
    JAMA Cardiol; 2019 Apr; 4(4):380-387. PubMed ID: 30865214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
    Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
    Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal hematopoiesis of indeterminate potential in persons with HIV.
    Knudsen AD; Eskelund CW; Benfield T; Zhao Y; Gelpi M; Køber L; Trøseid M; Kofoed KF; Ostrowski SR; Reilly C; Borges ÁH; Grønbæk K; Nielsen SD
    AIDS; 2024 Mar; 38(4):487-495. PubMed ID: 37976039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
    Burns SS; Kapur R
    Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
    Yu X; Qian N; Wang Y
    Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
    Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K
    J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic and Germline Variants and Coronary Heart Disease in a Chinese Population.
    Zhao K; Shen X; Liu H; Lin Z; Li J; Chen S; Liu F; Huang K; Cao J; Liu X; Shen C; Yu L; Zhao Y; Zhao L; Li Y; Hu D; Huang J; Lu X; Gu D
    JAMA Cardiol; 2024 Mar; 9(3):233-242. PubMed ID: 38198131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease.
    Akhiyat N; Lasho T; Ganji M; Toya T; Shi CX; Chen X; Braggio E; Ahmad A; Corban MT; Stewart K; Fernandez J; Xie Z; Finke C; Lerman LO; Patnaik MM; Lerman A
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):774-783. PubMed ID: 36951061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1.
    Saadatagah S; Naderian M; Uddin M; Dikilitas O; Niroula A; Schuermans A; Selvin E; Hoogeveen RC; Matsushita K; Nambi V; Yu B; Chen LY; Bick AG; Ebert BL; Honigberg MC; Li N; Shah A; Natarajan P; Kullo IJ; Ballantyne CM
    JAMA Cardiol; 2024 Apr; ():. PubMed ID: 38598228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
    Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G
    Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.